Emeryville drug developer Adamas files for $69 million IPO

Brain drug developer Adamas Pharmaceuticals Inc. hopes to raise $69 million as the fifth Bay Area life sciences company this year to file for an initial public offering...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.